<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://updates.zdnet.com/">
<channel>
	<title><![CDATA[schering-plough corp. Resources | ZDNet]]></title>
	<link><![CDATA[http://updates.zdnet.com/tags/schering-plough+corp..html]]></link>
	<description><![CDATA[White papers, case studies, technical articles, and blog posts relating to schering-plough corp.]]></description>
	<s:counts start="0" returned="2" found="2" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Drug profit incompatible with scientific method?]]></title>
		<link><![CDATA[http://healthcare.zdnet.com/?p=1311]]></link>
		<description><![CDATA[The NEJM editorial suggests a link may exist between Zetia or Vytorin and cancer, that Schering-Plough and Merck spun studies disputing the link for their own profit. by Dana Blankenhorn]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 03 Sep 2008 09:26:56 -0700</pubDate>
		<category domain="http://updates.zdnet.com/tags/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://updates.zdnet.com/tags/link.html"><![CDATA[Link]]></category>
		<category domain="http://updates.zdnet.com/tags/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://updates.zdnet.com/tags/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://updates.zdnet.com/tags/drug.html"><![CDATA[Drug]]></category>
		<category domain="http://updates.zdnet.com/tags/consumer+marketing.html"><![CDATA[Consumer Marketing]]></category>
		<category domain="http://updates.zdnet.com/tags/drugs.html"><![CDATA[Drugs]]></category>
		<category domain="http://updates.zdnet.com/tags/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://updates.zdnet.com/tags/government.html"><![CDATA[Government]]></category>
		<category domain="http://updates.zdnet.com/tags/dana+blankenhorn.html"><![CDATA[Dana Blankenhorn]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">MRK,SGP</category>
	</item>
	<item>
		<title><![CDATA[Schering-Plough Moves to Paperless Calibration]]></title>
		<link><![CDATA[http://whitepapers.zdnet.com/abstract.aspx?docid=254723]]></link>
		<description><![CDATA[FDA's compliance imperatives and guidelines for calibration set by ISPE in the GAMP Good Practice Guide for Calibration Management demand that pharmaceutical manufacturers establish robust calibration systems. Schering-Plough (Kenilworth, N.J.) installed a paperless calibration system at a number of its manufacturing facilities. The system, Prime Technologies' (West Chester, Pa.) ProCalV5,...]]></description>
		<s:doctype><![CDATA[Case studies]]></s:doctype>
		<category domain="http://updates.zdnet.com/tags/calibration.html"><![CDATA[Calibration]]></category>
		<category domain="http://updates.zdnet.com/tags/compliance.html"><![CDATA[Compliance]]></category>
		<category domain="http://updates.zdnet.com/tags/schering-plough+corp..html"><![CDATA[Schering-Plough Corp.]]></category>
		<category domain="http://updates.zdnet.com/tags/prime+technologies.html"><![CDATA[Prime Technologies]]></category>
		<category domain="http://updates.zdnet.com/tags/procalv5.html"><![CDATA[ProCalV5]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SGP</category>
		<category domain="tickers">SGP</category>
	</item>
</channel>
</rss>
